Quarterly ResultMay 8, 2026, 02:12 PM
InfuSystem Q1 Net Income $1.02M; EPS $0.05
AI Summary
InfuSystem Holdings, Inc. reported a significant improvement in its first-quarter 2026 financial results, turning a net loss into a profit. Net income reached $1.02 million, or $0.05 per diluted share, compared to a net loss of $0.27 million in the prior year. Gross profit increased to $19.68 million, while net revenues saw a slight decrease to $33.68 million. The company also continued its share repurchase program, buying back $11.8 million in stock.
Key Highlights
- Net income for Q1 2026 was $1.02 million, a significant improvement from a $0.27 million net loss in Q1 2025.
- Diluted EPS for Q1 2026 was $0.05, up from $(0.01) in Q1 2025.
- Gross profit increased to $19.68 million in Q1 2026 from $19.17 million in Q1 2025.
- Net revenues decreased slightly to $33.68 million in Q1 2026 from $34.72 million in Q1 2025.
- Operating income rose to $1.59 million in Q1 2026, compared to $0.62 million in Q1 2025.
- Patient Services segment generated $22.11 million in net revenues for Q1 2026.
- Device Solutions segment generated $11.58 million in net revenues for Q1 2026.
- The company repurchased $11.8 million of common stock under its program as of March 31, 2026.
Price Impact
More from INFU